Zynex organizacji Przewidiwany EPS Q/Q
Jaka jest wartość Przewidiwany EPS Q/Q organizacji Zynex?
Wartość Przewidiwany EPS Q/Q organizacji Zynex, Inc. to -17.39%
Jaka jest definicja Przewidiwany EPS Q/Q?
Perspektywiczna kwartalna stopa wzrostu z roka (Estimated quarterly EPS growth rate) rok do roku, to szacowany wzrost wartości EPS spółki na następny kwartał w porównaniu do wyników z poprzedniego kwartału.
The prospective EPS growth rate is a predicted estimate of the earnings per share growth rate towards the current quarter and expressed as a percentage compared to the respective past quarter. The estimated earnings per share growth rate is an important factor for judging a company's value. Comparing EPS history with stock price history helps determine the most likely future direction of the stock price.
Earnings per share is the monetary value of earnings per outstanding share of common stock for a company. The EPS is usually calculated as profit without preferred dividends divided by weighted average of common stock shares over the past twelve months.
Przewidiwany EPS Q/Q firm w Health Care sektor na EURONEXT w porównaniu do Zynex
Czym się zajmuję organizacja Zynex?
Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device that is marketed to physicians and therapists by field sales representatives; NeuroMove, an electromyography triggered electrical stimulation device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; and E-Wave, an NMES device. It also supplies private labeled products, including electrodes for the delivery of electrical current to the body, and batteries for use in electrotherapy products. In addition, the company distributes Comfortrac/Saunders for cervical traction, JetStream for hot/cold therapy, LSO Back Braces for lumbar support, and knee braces for knee support. Further, it offers Zynex Fluid Monitoring System (CM-1500), a fluid volume monitor, which is a non-invasive medical device for monitoring relative fluid volume changes used in operating and recovery rooms to detect fluid loss during surgery and internal bleeding during recovery; Zynex Wireless Fluid Monitoring System (CM-1600), a noninvasive monitoring device designed to measure relative changes in fluid volume in adult patients; NiCO CO-Oximeter, a laser-based noninvasive co-oximeter; and HemeOx tHb Oximeter, a laser-based total hemoglobin pulse oximeter. The company provides its products for use in pain management and control; stroke and spinal cord injury rehabilitation; hemodynamic monitoring; and pulse oximetry monitoring. It sells its products through direct sales force primarily in the United States. Zynex, Inc. was founded in 1996 and is headquartered in Englewood, Colorado.
Firmy z przewidiwany eps q/q podobne do Zynex
- Wartość Przewidiwany EPS Q/Q organizacji VEREIT Inc to -17.50%
- Wartość Przewidiwany EPS Q/Q organizacji 1+1 Ag Inh O.N to -17.50%
- Wartość Przewidiwany EPS Q/Q organizacji Tencent to -17.50%
- Wartość Przewidiwany EPS Q/Q organizacji SiTime Corp to -17.48%
- Wartość Przewidiwany EPS Q/Q organizacji Designer Brands Inc to -17.44%
- Wartość Przewidiwany EPS Q/Q organizacji Markel Inc to -17.41%
- Wartość Przewidiwany EPS Q/Q organizacji Zynex to -17.39%
- Wartość Przewidiwany EPS Q/Q organizacji AGNC Investment Corp to -17.33%
- Wartość Przewidiwany EPS Q/Q organizacji Biolase Inc to -17.33%
- Wartość Przewidiwany EPS Q/Q organizacji Tennant Co to -17.29%
- Wartość Przewidiwany EPS Q/Q organizacji Orchard Therapeutics plc to -17.24%
- Wartość Przewidiwany EPS Q/Q organizacji Kaleyra Inc to -17.24%
- Wartość Przewidiwany EPS Q/Q organizacji Celanese Corp to -17.22%